Focal nodular hyperplasia and hepatic adenoma: a review of eight cases in the pediatric age group

A review of all primary hepatic tumors seen at Children's Hospital, Boston over a 57-year period disclosed six cases of focal nodular hyperplasia (FNH) and two hepatic adenomas (HA). The children with FNH (four females, two males) ranged in age from 6 months to 15 years (average age: 7 years). Three patients had "hepatomegaly" noted on physical examination 2 months to 2 or more years prior to diagnosis. The average diameter of FNH was 7.3 cm (range 2.5-10 cm). The lesion was confined to the right lobe in four cases and showed bilobar involvement in two. The HA's were diagnosed in a newborn male and a 2-year-old girl, both of whom were symptomatic because of large tumor size (10 cm each). There was no maternal history of exposure to exogenous steroids during pregnancy. Three children with FNH underwent hepatic lobectomy and were alive and well 4 to 17 years later. One child who died of acute leukemia had an incidental FNH discovered at autopsy. Two patients were treated conservatively with biopsy only and were alive and symptom-free 13 and 15 years later. Both children with HA underwent hepatic lobectomy. One died postoperatively because of intra-abdominal hemorrhage and the other was alive and well 10 1/2 years later. Complete surgical resection is recommended for most children with HA when technically feasible because of the lingering suspicion of possible (albeit remote) malignant transformation and diagnostic difficulties in distinguishing HA from a well-differentiated hepatocellular carcinoma.     

Fibrocartilaginous mesenchymoma with low-grade malignancy

In a review of cases of fibrous cartilaginous dysplasia of bone, five of fibrocartilaginous lesions were found to be different in clinical behavior and radiographic and morphologic features from the others. We have named these previously undescribed tumors fibrocartilaginous mesenchymomas with low-grade malignancy in the fibrous elements.Dr. Bertoni is a visiting surgical pathologist from the Servizio di Anatomia ed Istologia Patologica, Bologna, Italy     

恶性肿瘤合并静脉血栓栓塞症患者危险因素分析

目的：分析恶性肿瘤合并静脉血栓栓塞症（VTE）患者的危险因素。方法：选取2020年1月至2022年1月陆军第73集团军医院进行治疗的133例恶性肿瘤患者,对患者一般资料进行回顾性分析,比较恶性肿瘤组患者及恶性肿瘤合并VTE组患者一般资料,通过多因素logistic回归分析明确恶性肿瘤合并VTE的危险因素,比较两组患者1年死亡率。结果：两组患者肿瘤分期、冠心病、化疗、合并感染、激素治疗、中心静脉置管构成比及纤维蛋白原（FIB）、D–二聚体（D–D）、活化部分凝血活酶时间（APTT）、血管性血友病因子（vWF）水平比较,差异具有统计学意义（P <0.05）;多因素logistic回归分析结果表明肿瘤分期Ⅲ～Ⅳ期、有冠心病、有化疗、有感染、有激素治疗及有中心静脉置管、血浆D–D水平高为恶性肿瘤合并VTE危险因素,差异具有统计学意义（P <0.05）。多因素logistic回归分析结果表明,肿瘤分期Ⅲ～Ⅳ期、有冠心病、有化疗、有感染、有激素治疗及有中心静脉置管、血浆D–D水平高为恶性肿瘤合并VTE危险因素（P <0.05）;恶性肿瘤合并VTE组患者1年死亡率明显高于恶性肿瘤组...     

2015年四川省胃癌和食管癌发病及死亡分析

目的分析2015年四川省上消化道恶性肿瘤(胃癌和食管癌)发病、死亡和潜在减寿情况。方法收集四川省24个肿瘤登记处上报的2015年恶性肿瘤发病、死亡及人口资料。提取ICD-10编码C15-C16选择食管癌、胃癌的发病和死亡数据,用SAS 9.3软件分别计算性别、年龄别发病和死亡的粗率、标化率、构成比、累积率(0~74岁)、潜在减寿年数(potential years of life lost,PYLL)、潜在减寿率(potential years of life lost rate,PYLLR)和平均减寿年(average years of life lost,AYLL)。标准人口采用2000年全国普查人口年龄构成和Segi’s世界人口年龄构成。结果2015年四川省肿瘤登记地区食管癌和胃癌发病率分别为29.29/10万和28.60/10万,分别居发病第3位和第4位;胃癌和食管癌死亡率分别为23.90/10万和22.20/10万,分别居死亡第3位和第4位;根据上消化道恶性肿瘤发病率和死亡率的年龄性别分布,男女性45岁后发病率和50岁后死亡率均显著升高;无论城乡,男性食管癌和胃癌各项发病和死亡指标均高于女性。农村地区人群食管癌和胃癌疾病负担高于城市。食管癌潜在减寿年数为23399人年,平均减寿年数为15.41年,减寿率为1.92‰;胃癌潜在减寿年数为25390人年,平均减寿年数为16.74年,减寿率为2.09‰。结论四川省食管癌和胃癌发病与死亡水平相对较高,男性为食管癌和胃癌的高发人群,45岁以上的中老人群是上消化道恶性肿瘤高风险人群,农村地区人群的上消化道肿瘤疾病负担高于城市。     

CT在卵巢肿瘤中的应用价值

目的 :评价卵巢肿瘤的CT诊断价值。方法 :搜集经手术和病理证实的 2 0例卵巢肿瘤 ,对其CT表现作回顾性分析。结果 :2 0例卵巢肿瘤中 ,单纯性卵巢囊肿 2例 ,卵巢成熟性畸胎瘤 4例 ,卵巢甲状腺肿 1例 ,卵巢囊腺瘤 3例 ,卵巢无性细胞瘤1例 ,卵巢颗粒细胞瘤 1例 ,卵巢癌 8例。结论 :CT对卵巢肿瘤的定位及定性诊断有重要的价值 ,但对卵巢良、恶性肿瘤的鉴别须结合病史和年龄。     

卵巢肿瘤的CT诊断

目的 :探讨卵巢肿瘤的CT诊断价值。方法 :分析 2 8例经手术病理证实的卵巢肿瘤的CT表现。结果 :良性肿瘤绝大多数表现为边界光整的薄壁囊性肿块 ;恶性肿瘤呈实质性或混合性 ,边缘不光整 ,增强后实质强化明显 ,并且多见转移征象。结论 :CT对卵巢良恶性肿瘤的鉴别很有价值。     

经阴道、会阴超声诊断直肠肿瘤的临床价值

目的探讨经阴道、会阴超声诊断直肠肿瘤的临床价值。方法直肠灌水后经阴道、会阴超声检查直肠肿瘤病人28例,并与正常人20例,直肠腔内超声16例对照,同时5例肿瘤作了标本超声检查。结果 28例患者中,26例检出直肠肿瘤28个,其部位在距肛门口2.5～15cm范围内,2例经阴道、会阴超声未发现肿瘤。直肠灌水后经阴道会阴超声检查可直观显示肿瘤的形态,与标本超声显示一致;其病理分期的符合率分别为80.8％。发现淋巴结肿大5例。尤其对高位直肠肿瘤或肿瘤致直肠严重狭窄的病例或Miles手术后,更具有价值。结论经阴道、会阴超声可作为直肠肿瘤检查的补充方法。     

脑星形细胞瘤中神经细胞黏附分子与PCNA的表达及其关系

目的 :研究人脑星形细胞瘤中神经细胞黏附分子 (neuralcelladhesionmolecule ,NCAM)的表达情况及其与肿瘤增殖活性 (PCNA)的相关性。方法 :收集人脑星形细胞瘤标本 48例 ,行SP法染色。结果 :正常脑组织NCAM全部表达 ,星形细胞瘤中I～II级、III级、IV级组阳性表达率分别为 95 % (1 9/ 2 0 ) ,3 8 9% (7/ 1 8)和 2 0 % (2 / 1 0 ) ,阳性细胞表达程度随肿瘤恶性程度的增高反而降低。其表达程度与PCNA免疫反应分数 (IRS)呈负相关 (r =- 0 .6 5 7,P <0 .0 5 )。结论 :随人脑星形细胞瘤恶性程度的增高 ,NCAM表达下调 ,提示NCAM表达减少参与肿瘤的生物恶性发展。     

30例肾上腺肿瘤的CT表现特征分析

目的分析肾上腺肿瘤的CT表现特征. 方法回顾性分析30例经手术病理证实的各类肾上腺肿瘤的CT征像,提出诊断与鉴别诊断的要点.结果纤维黄色瘤呈中等度大小,密度不均匀,轻度强化 ;嗜铬细胞瘤肿块较大,密度不匀,强化明显;髓性脂肪瘤CT值呈脂肪密度;囊肿的CT值偏低,囊肿壁可有钙化;醛固酮腺瘤小,密度低;皮质醇腺瘤中等大小,中等密度;皮质腺癌肿块较大且不规则,内有低密度区;肾上腺转移癌肿块较大,密度不均匀.结论认真分析影像学特征,提高肾上腺肿瘤诊断的准确率是可能的.     

La densidad de los ganglios linfáticos en la linfadenectomía retroperitoneal como marcador novel para predecir la recurrencia en pacientes con cáncer testicular de células germinales: estudio de casos y controles y experiencia clínica a largo plazo de un hospital de referencia terciario

Introduction and objectivesIn this retrospective study, we aimed to evaluate lymph node (LN) density in retroperitoneal lymph node dissection (RPLND) to analyze whether residual mass after chemotherapy might behave as predicting factor for recurrence in patients with germ cell testicular cancer (GCTC).Materials and methodsThe data of 185 patients that were operated between 12/2004 and 02/2017 because of GCTC were reviewed retrospectively. LN density was calculated. The patients were compared statistically in terms of demographic features, tumor characteristics, serum tumor marker levels, treatment strategies, and pathological results according to GCTC subtypes. Correlation analysis was performed to determine the parameters related to recurrent disease.ResultsThe median follow-up was 79 (31-179) months and the median age of the patients was 23 (16-71). The median tumor size was 4 (1-18) cm. Five (2.7%) patients had metastatic disease at initial diagnosis. Seminoma, non-seminomatous-GCT and mix type-GCTC was detected in 62 (33.5%), 60 (32.4%) and 63 (34.1%) patients, respectively. Following inguinal orchiectomy, 48 (25.9%) patients underwent follow-up, 126 (68.1%) patients underwent chemotherapy and 11 (5.9%) patients underwent radiotherapy. A total of 21 (11.4%) patients underwent post-chemotherapy RPLND. Early and late recurrence was seen in 3 (1.6%) and 2 (1.1%) of the patients, respectively. A mild to moderate, negative, but significant correlation was found between the recurrence and the number of LNs containing metastatic deposits and LN density (r= –0.490, P=.024 and r= –0.450, P=.041, respectively).ConclusionsThere was a negative correlation between the number of LNs containing metastatic deposits and LN density and recurrent disease.